Friday, December 26, 2014


Dr Reddys Laboratories Ltd  has filed a clarification statement with the exchanges  stating  that In keeping with current regulations of Health Canada, the Company has voluntarily placed under quarantine all APIs and the formulations based on APIs produced at our API facility in Srikakulam district of Andhra Pradesh intended for use in Canada. Its products continue to meet intended quality standards, and they believe that, its APIs and Finished drug products manufactured using these APIs pose no risk to the health and safety of the Canadian people. The Company is working with the agency for a satisfactory resolution of the matter. At this stage, it has no implication on any activity at the plant and hence, these are not expected to be material to the Company's operations or consolidated results.

No comments:

Post a Comment